Hot penny stocks... don't get burned
Research Report
Michael S. Wyzga is a Chief Financial Officer of Genzyme Cp. Hotstocked.com has a complete research report available for GENZ stock. Download GENZ report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download GENZ report
  
Example preview: Research report for Genzyme Cp (GENZ) Research report for Genzyme Cp (GENZ) Research report for Genzyme Cp (GENZ) Research report for Genzyme Cp (GENZ)
   

Michael S. Wyzga

Rate this Executive:
Not rated yet Not rated yet.
This is a page dedicated to get more information for investors to evaluate the management style of Michael S. Wyzga who is a Chief Financial Officer of Genzyme Cp.

Here on this page we are inviting all readers to discuss Michael S. Wyzga. You may anonymously post comments with any information that they have about Michael S. Wyzga. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

User comments


Type the characters that you see in the box (5 characters).

This is a captcha-picture. It is used to prevent mass-access by robots. (see: www.captcha.net)

  

I would like to be notified by e-mail if someone comments on this page. Email confirmation needed. Privacy Statement.
   
   
   
   
Here is a copy of personal Bio that we found:
Name: Michael S. Wyzga
Age: 53
Mr. Wyzga has served as Executive Vice President, Finance since May 2003, as Chief Accounting Officer since January 1999 and as Chief Financial Officer since July 1999. He joined us in February 1998 as Vice President and Corporate Controller and served as Senior Vice President, Corporate Controller from January 1999 until July 1999. He served as Senior Vice President, Finance from July 1999 until May 2003. From February 1997 to February 1998 Mr. Wyzga served as Chief Financial Officer of Sovereign Hill Software, Inc., a software company, and from 1991 to 1997 held various senior management positions with CACHELINK Corporation and Lotus Development Corporation. Mr. Wyzga is also director of Altus Pharmaceuticals Inc., a developer of protein therapeutics.
« Mark O. Thornton MD, MPH, PhD Mandeep K. Taneja »
   
   
Company name Officer position Pay Exercised
Genzyme Cp Chief Financial Officer, Chief Accounting Officer and Exec. VP of Fin. $ 895.00K $ 3.34M
   
 
Home > Officers > Michael S. Wyzga